tiprankstipranks
Trending News
More News >
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market

Skye Bioscience (SKYE) Income Statement

Compare
891 Followers

Skye Bioscience Income Statement

Last quarter (Q3 2025), Skye Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Skye Bioscience's net income was $-12.75M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.87K
Operating Expenses
$ 30.19M$ 34.74M$ 18.31M$ 7.85M$ 6.29M
Depreciation and Amortization
$ 298.64K$ 124.25K$ 115.00K$ 34.13K$ 1.87K
EBITDA
$ -25.29M$ -36.62M$ -18.70M$ -7.72M$ -5.85M
Operating Income
$ -30.19M$ -34.74M$ -18.31M$ -7.85M$ -6.29M
Other Income/Expenses
$ 3.64M$ -2.91M$ -1.16M$ -672.37K$ -270.00K
Pretax Income
$ -26.56M$ -37.64M$ -19.47M$ -8.52M$ -6.56M
Net Income
$ -26.57M$ -37.64M$ -19.48M$ -8.52M$ -6.56M
Per Share Metrics
Basic EPS
$ -0.73$ -5.37$ -8.77$ -5.00$ -7.11
Diluted EPS
$ -0.73$ -5.37$ -8.77$ -5.00$ -7.46
Weighted Average Shares Outstanding
36.49M 7.01M 2.22M 1.63M 922.99K
Weighted Average Shares Outstanding (Diluted)
36.49M 7.01M 2.22M 1.63M 925.68K
Currency in USD

Skye Bioscience Earnings and Revenue History